AFP and neoplasm: Beyond classical tumor and genetic markers—including CEA, CA-125, CA-19-9, PSA, AFP, LDH, BRCA1, BRCA2, RB1, MEN1, and MEN2A—emerging approaches also consider epigenetic modifications, such as DNA methylation and mRNA expression, as predictors of malignant transformation.